Label Changes for:

MultiHance (gadobenate dimeglumine) Injection and MultiHance Multipack (gadobenate dimeglumine) Injection

July 2013

Changes have been made to the WARNINGS and PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

 

July 2013

WARNINGS AND PRECAUTIONS

Hypersensitivity Reactions
  • If such a reaction occurs stop MultiHance and immediately begin appropriate therapy.
Hide
(web5)